PriceSensitive

Mcmillan Shakespeare (ASX:MMS) appoints Rob De Luca as CEO and MD

ASX News, Finance
ASX:MMS      MCAP $1.274B
17 March 2022 16:34 (AEST)

Mr Rob De Luca Source: The CEO Group

McMillan Shakespeare (MMS) announced the appointment of Rob De Luca as CEO and Managing Director, taking over from retiring Mike Salisbury, effective on May 16.

Mr Salisbury has been with the company for 14 years, leading MMS as CEO and MD since 2014.

Mr De Luca is a CEO with over 20 years of experience in banking, financial services and wealth management. Over his tenures, he has led and grown organisations through periods of significant technological, economic and regulatory change.

Having started his career as a Credit Analyst at NAB, he quickly rose through the ranks through General Manager roles in various banks and wealth management companies, to most recently as CEO of Zenitas Healthcare and was the former Managing Director of Bankwest.

McMillan said a “seamless transition” is being implemented over the coming months.

“Rob has a unique blend of proven financial services leadership and NDIS experience,” said MMS Chair Helen Kurincic.

“The Board has been clear in the attributes required to lead MMS through this exciting next chapter including proven business growth through strategy execution, customer centricity and innovation through technology”.

Mr De Luca will receive $800,000 per annum inclusive of superannuation as part of his remuneration package.

McMillan will also provide Mr De Luca with an STI opportunity of $400,000, commencing FY23. The STI will be determined by the MMS Board based on the achievement of financial and non-financial hurdles.

Subject to shareholder approval, MMS will grant Mr De Luca indeterminate rights to the value of $800,000 commencing FY23.

MMS shares finished the day 3.75 per cent in the green, up to $11.89.

Related News